Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/10/2008CN100441175C Use of compounds for the prevention of drug-induced cell toxicity
12/10/2008CN100441174C Use of diphenylmethane derivatives as tyrosinase inhibitors
12/10/2008CN100441169C Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
12/10/2008CN100441158C Cooling compositons
12/10/2008CN100441156C Intrauterine device of composite material
12/10/2008CN100441105C Composition comprising cysteamine for specific use in poultry raising and egg production
12/10/2008CN100441096C Microbicidal composition
12/09/2008US7462741 e.g. N-[(2S)-3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propanamide; N-[(2S)-3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propanamide; melatonin receptor antagonist; antidepressant, anxiolytic agent; sleep disorders, stress, cardiovascular and digestive system pathologies, schizophrenia, obesity, epilepsy
12/09/2008US7462735 e.g. 4-[4-(hydroxybenzoylamino)benzoylamino]butanoic acid; antithrombotic, antiinflammatory, anticarcinogenic agent, antiallergen; mixture with heparin or glycosaminoglycan oligosaccharides; increase the oral absorption of heparin
12/09/2008US7462724 e.g. 2-{4-[1-(cyclohexylmethylamino)ethyl]phenyl}-1H-benzimidazole-4-carboxamide; poly-ADP-ribose polymerase inhibitor; antiinflammatory, anticarcinogenic, antidiabetic, antiischemic agent; neurodegenerative diseases
12/09/2008US7462723 e.g. N1-[(E)-1-(4-fluorophenyl)methylidene]-4-(1,3-thiazol-2-yl)-1H-1,2-imidazolediamine; anticarcinogenic agent; sid effect reduction
12/09/2008US7462721 Aza-quinolinol phosphonate integrase inhibitor compounds
12/09/2008US7462717 e.g. 3-{4-[3-(4-fluoro-phenyl)-2-methyl-allyl]-piperazin-1-ylmethyl}-7,8-dimethoxy-3a,4-dihydro-3H-chromeno [4,3-c]isoxazol-6-yl)-pyridin-4-yl-amine; serotonin (5-HT) reuptake inhibitor and alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; psycosis, Parkinson's disease
12/09/2008US7462716 Statin derivatives
12/09/2008US7462713 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
12/09/2008US7462712 reacting keto ester corresponding compound with phosphorohalide in presence of basic catalyst
12/09/2008US7462710 Modified gum arabic
12/09/2008US7462705 Nucleic acids encoding an enediyne polyketide synthase complex
12/09/2008US7462703 For use in gene therapy
12/09/2008US7462691 Prostate stem cell antigen (PSCA) tumor antigen for use in diagnosis, prevention and treatment of prostate cancers
12/09/2008US7462647 Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators
12/09/2008US7462646 Osteoclastogenesis inhibitors and uses thereof
12/09/2008US7462645 Bronchodilating beta-agonist compositions and methods
12/09/2008US7462644 Therapy for lipid disorders; dyslipidemia; insulin resistance; antidiabetic agents; 4-(2-(((2,6-dichlorophenyl)methyl)thio)ethyl) amino)-2-oxoethoxxy methoxybenzenepropanoic acid
12/09/2008US7462643 Essential fatty acids in the prevention of cardiovascular events
12/09/2008US7462642 Anti-cancer combinations
12/09/2008US7462641 (2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
12/09/2008US7462640 e.g. 5-Chloro-3-methyl-N-[1-[2-(pyrrolidin-1-yl)ethyl-1H-indol-6-yl]-benzo[b]thiophene-2-sulfonamide; serotonin receptor modulator; anxiolytic agent, antidepressant; nervous and gastrointestinal disorders, antidiabetic agent; bipolar disorders, cognitive memory disorders, neurodegenerative disorders
12/09/2008US7462639 e.g 3-(7,7-Dimethyl-6-oxo-1,5,6,7-tetrahydro-imidazo[4,5-f]indol-2-yl)-1H-pyrazol-4-yl]-carbamic acid benzyl ester; Aurora A (serotonin/threonine) kinase inhibitors; anticarcinogenic agent; colorectal, breast, lung, prostate, pancreatic, gastric, bladder, ovarian cancer, melanoma, neuroblastoma
12/09/2008US7462638 Use of IκB-kinase inhibitors in pain therapy
12/09/2008US7462637 Derivatives of [6,7-dihydro-5H-imidazo[1,2--a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
12/09/2008US7462636 Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
12/09/2008US7462635 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia
12/09/2008US7462634 N-(pyridin-2-yl)-sulfonamide derivatives
12/09/2008US7462633 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
12/09/2008US7462632 Method for the preparation of N-piperidino-1, 5-diphenylpyrazole-3-carboxamide derivatives
12/09/2008US7462631 e.g. 4-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-3-methyl-N-piperidin-1-ylthiophene-2-carboxamide; cannabinoid receptor antagonist; antiinflammatory agent; obesity, gastrointestinal disorders, inflammatory phenomena, immune system diseases, psychotic disorders, alcohol and nicotine dependence
12/09/2008US7462630 Diarylalkene derivatives and novel diarylalkane derivatives
12/09/2008US7462629 Therapy or prevention diseases caused by lymphocyte interaction; antiinflammatory agents; autoimmune disease
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/09/2008US7462627 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
12/09/2008US7462626 Compositions for affecting weight loss
12/09/2008US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/09/2008US7462624 Purinone derivatives as HM74a agonists
12/09/2008US7462623 Quinazoline derivatives as Src tyrosine kinase inhibitors
12/09/2008US7462622 Pyrrolo[2, 3-d] pyrimidine derivatives as corticotropin releasing factor antagonists
12/09/2008US7462621 9-[3-(2-Fluorophenyl)-propyl]-7,7-dimethyl-2-(pyridin-4-yl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; neurodegenerative disease caused by abnormal activity of GSK3 beta (glycogen synthase kinase beta 3) or GSK3 beta and cdk5/p253
12/09/2008US7462620 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
12/09/2008US7462619 Pyridazine, pyrimidine and pyrazine ethyne compounds
12/09/2008US7462618 Treatment of inflammatory autoimmune diseases with alpha-adrenergic antagonists and beta-adrenergic agonists
12/09/2008US7462617 Substituted acylpiperazine derivatives
12/09/2008US7462616 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
12/09/2008US7462615 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
12/09/2008US7462614 7-(2-Bromophenyl)-5-methyl-N-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine; to treat neoplasms; polo like kinases inhibitors; antineoplastic/antiproliferative agents; cyclization of 1,2,4-triazine derivatives; coupling if imidazo[5,1-f][1,2,4]triazines with amine or halogen derivatives
12/09/2008US7462613 Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
12/09/2008US7462612 Pyridine inhibitors of ERK2 and uses thereof
12/09/2008US7462611 Pyrro[1,2-b]pyridazinone compounds
12/09/2008US7462610 Prostate cancer treatment
12/09/2008US7462609 Narcistatin prodrugs
12/09/2008US7462608 Non nucleoside reverse transcriptase inhibitors
12/09/2008US7462607 Therapy-enhancing glucan
12/09/2008US7462606 Antiseptics; surgery; controlling release of drugs
12/09/2008US7462605 Phosphoramidate compounds and methods of use
12/09/2008US7462604 excellent stabilization effect at low temperature; no stickiness; Glycerin monopentadecanoate with 6-benzylaminopurine and/or the derivatives, polyglycerin fatty acid esters, sorbitan fatty acid esters
12/09/2008US7462603 Artificial micelle comprising shuttle vector for use as tool in efficient gene transfer to cells
12/09/2008US7462601 Ameliorant for chemical treatment of cancer
12/09/2008US7462600 Macrolides
12/09/2008US7462599 Use of effectors of glutaminyl and glutamate cyclases
12/09/2008US7462594 Peptide like compounds for treating coronavirus or aviviridae virus; severe acute respiratory distress syndrome
12/09/2008US7462592 Compositions and methods for polynucleotide delivery
12/09/2008US7462465 Nucleic acid encoding KCNB potassium channel
12/09/2008US7462370 Purified bilberry extract containing a mixture of glycosides of delphinidin, cyanidin, petunidin, peonidin, and malvidin; no added bisulfite ions; nutraceuticals and pharmaceuticals
12/09/2008US7462369 Anti-viral compositions and methods of making and using the anti-viral compositions
12/09/2008US7462368 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino]butanoate
12/09/2008US7462367 Anticholinergic powder formulations for inhalation
12/09/2008US7462366 Drug delivery particle
12/09/2008US7462362 10 weight % terbinafine hydrochloride, 0.5 % dodecyl 2-(N,N-dimethylamino)propionate hydrochloride and 0.75 % benzyl alcohol to enhance penetration; 0.5 % polyvinylpyrrolidone, and the remainder ethanol; duel delivery through nail and skin increases topical bioavailability; onychomycosis
12/09/2008US7462361 N,N-dihalogenated amino acids and derivatives
12/09/2008US7462357 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
12/09/2008US7462351 dextrin polymers in combination with sugars provide enhanced delivery of nucleic acids, particularly eucaryotic expression vectors, demonstrate enhanced delivery of nucleic acids to cells in vivo
12/09/2008CA2515094C Transdermal granisetron
12/09/2008CA2462998C Novel estrogenic compounds
12/09/2008CA2462807C Decontamination of surfaces contaminated with prion-infected material with gaseous oxidizing agents
12/09/2008CA2425368C New sulphoxybenzamides
12/09/2008CA2419296C New macrolides with antibacterial activity
12/09/2008CA2417875C Polymorphs of zaleplon and methods for the preparation thereof
12/09/2008CA2415447C Novel .gamma. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
12/09/2008CA2405553C Bone-strengthening agent, bone-strengthening food and bone-strengthening feed composition
12/09/2008CA2389650C Composition for treatment of constipation and irritable bowel syndrome
12/09/2008CA2388142C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
12/09/2008CA2387953C Compositions for electroporation
12/09/2008CA2385871C Ltb4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
12/09/2008CA2382919C Bicyclic imidazo-3-yl-amine derivatives
12/09/2008CA2379061C Antibacterial agents
12/09/2008CA2352054C New amidino derivatives and their use as thrombin inhibitors
12/09/2008CA2346896C 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders
12/09/2008CA2337804C Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
12/09/2008CA2326485C Anticancer compositions
12/09/2008CA2326045C Pde iv inhibiting pyridine derivatives
12/09/2008CA2323805C Analgesic combination comprising nmda receptor antagonists and narcotic analgesics
1 ... 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 2979 2980 2981 2982 ... 7860